A carregar...
Increased Risk of Stroke with Darbepoetin Alfa in Anaemic Heart Failure Patients with Diabetes and Chronic Kidney Disease
AIMS: The use of an erythropoetic stimulating agent, darbepoetin alfa (DA), to treat anaemia in patients with diabetes mellitus and chronic kidney disease was associated with a heightened risk of stroke and neutral efficacy in The Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT), d...
Na minha lista:
| Publicado no: | Eur J Heart Fail |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4703474/ https://ncbi.nlm.nih.gov/pubmed/26423928 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ejhf.412 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|